Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand
- 14 December 2021
- journal article
- research article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (1) , 62-67
Abstract
Objective: To establish the epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa (EB) in New Zealand (NZ).Methods: Participants were recruited through the Dystrophic Epidermolysis Bullosa Research Association of New Zealand (DEBRA NZ). Dedicated EB nurse medical records, Genetic Health Service NZ (GHSNZ) records and, where available, public hospital records were manually reviewed for relevant clinical data.Results: Ninety‐two participants took part in the study (56% participation rate). Forty‐nine (53%) participants had EB simplex (EBS), 40 (43%) had dystrophic EB (DEB), and 3 (3%) had junctional EB (JEB). Point prevalence for EB of all types was 19.5 per million, and 10.4, 8.6 and 0.9 per million for EBS, DEB and JEB, respectively. Thirty‐four participants had intermediate or severe EB. There were 29 paediatric cases and almost even numbers of males and females. Compared to NZ European and Māori, prevalence rates were lower for Pacific and Asian people and higher in the Middle Eastern/Latin American/African population. Eight out of 14 skin biopsy results were informative, and 14 of 15 genetic test results were informative.Conclusion: New Zealand has similar prevalence rates of EB compared with other national cohorts. This is likely to be an underestimate due to methodological limitations. Recent advancements in genomic testing have resulted in an improved diagnostic rate in our population. Further research into ethnic differences in prevalence, and exploring the characteristics of lethal forms of EB, is warranted. A dynamic registry may be helpful for the EB community in NZ.Keywords
Funding Information
- Debra International (2500 Euros)
This publication has 12 references indexed in Scilit:
- From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB)Clinical, Cosmetic and Investigational Dermatology, 2019
- Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosaBritish Journal of Dermatology, 2019
- A retrospective cohort study evaluating the accuracy of clinical diagnosis compared with immunofluorescence and electron microscopy in children with inherited epidermolysis bullosaBritish Journal of Dermatology, 2019
- Clinical subtypes and molecular basis of epidermolysis bullosa in KuwaitInternational Journal of Dermatology, 2018
- Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa RegistryJAMA Dermatology, 2016
- Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classificationJournal of the American Academy of Dermatology, 2014
- Prevalence of Dystrophic Epidermolysis Bullosa in Spain: A Population-Based Study Using the 3-Source Capture–Recapture Method. Evidence of a Need for Improvement in CareActas Dermo-Sifiliograficas, 2013
- Epidemiology of Epidermolysis Bullosa in the AntipodesArchives of Dermatology, 2010
- Epidermolysis Bullosa in JapanDermatologic Clinics, 2010
- Studies on the Pathogenesis of Epidermolysis Bullosa**From the Section of Dermatology, Department of Medicine, University of Chicago, Chicago 37, Illinois.Journal of Investigative Dermatology, 1962